Sat Jul 31, 2010 10:27
Featured Company
Company Main Page
XINGLIN MEDICAL (8130)
HSI: 21,029.81 -64.01
0.037
0.001 (2.6%)
As of16:05 30 Jul 2010
Open: 0.038 52Wk High: 0.68
Day High: 0.041 52Wk Low: 0.024
Day Low: 0.036 P/E: 0.00
Prev. Close: 0.038 Yield: 0.00%
Volume: 221.36M
Mkt Cap: 360.72M
Turnover: 8.43M NAV: 0.165
Quotes are delayed by at least 15 minutes.
Announcements
30 Jul 2010
Announcement: Notice Of Board Of Directors' Meeting
13 Jul 2010
Announcement: Notice Of The Special General Meeting
08 Jul 2010
Announcement: Company Information Sheet
08 Jul 2010
Announcement: Next Day Disclosure Returns
06 Jul 2010
Announcement: Monthly Return of Equity Issuer on Movements in Securities For The Month Ended 30 June 2010
MORE >
Circulars
13 Jul 2010
Circular: (I) Capital Reorganisation;(Ii) Change In Board Lot Size And (Iii) Notice Of Special General Meeting
02 Jul 2010
Circular: (1) Proposed Grant Of General Mandates To Issue And Repurchase Shares; (2) Proposed Re-Election Of Directors; (3) Proposed Refreshment Of The Limit Of The Existing Share Option Scheme; And (4) Notice Of Annual General Meeting
09 Nov 2009
Circular: Proposed Placing Of New Shares Subject To Shareholders' Approval And Notice Of Special General Meeting
07 Sep 2009
Circular: Proposed Change Of Company Name And Notice Of Special General Meeting
24 Aug 2009
Circular: Very Substantial Acquisition; Proposed Increase In Authorised Share Capital; And Notice Of Special General Meeting
MORE >
Financial Reports
2010 Annual Report
2009 Third Quarterly Report
MORE >
Proxy Forms
13 Jul 2010
Proxy Form
02 Jul 2010
Proxy Form
09 Nov 2009
Proxy Form
07 Sep 2009
Form of proxy for use at the Special General Meeting to be held on Monday, 5 October 2009 at 4:30 p.m.
24 Aug 2009
Proxy Form
MORE >
Company Profile

Principally engaged in the provision of film production services, production of television movies, investment in film productions and worldwide film distribution and properties investment.

Business Review - For the year ended March 31, 2009

Owing to the global economic downturn, the operating environment of the film industry has been increasingly challenging. Given the above, the Group has been alert and cautious in utilising its resources for the production of new films. The Group recorded a turnover of approximately HK$1.6 million (2008: HK$10.6 million) during the year under review. The Group did not have revenue generated from the business segment of film production and distribution. All of the revenue was generated from the leasing of the investment property located at Canada.

On 26 November 2008, the Company entered into a subscription agreement with Golife Concepts Holdings Limited, whose shares are listed on the GEM of the Stock Exchange, in respect of the subscription of convertible bonds in an aggregate principal amount of HK$100 million in five tranches of HK$20 million each (the “Subscription”). The Subscription constituted a very substantial acquisition of the Company under the GEM Listing Rules. A circular containing the details of the Subscription had been despatched to the shareholders of the Company on 29 December 2008. The Subscription was subsequently approved by the Company’s shareholder at the extraordinary general meeting held on 14 January 2009. The Company subscribed the convertible bonds in the principal amount of HK$100 million on 28 April 2009.

Source: XingLin Medical (08130) Annual Results Announcement

Financial Highlights
(HK$m)
2010
Final
Turnover 18.96
Operating Profit 41.43
Pre-Tax Profit/Loss -73.55
Net Profit/Loss -74.20
Earnings Per Share(cents) -0.03
MORE >
Dividends
Year End Ex-Date (HK$)
Amount
Chairman
AuHo Chuen, Bonny Chairman
Financial Ratios
2010
Final
Gross Profit Margin 218.48
Asset To Equity Ratio 142.16
MORE >
Contact Info
Company Address:
Unit 1611, 16/F., Shun Tak Centre, West Tower, 168-200 Connaught Road Central, Hong Kong
Web: http://www.bamm.com.hk
Research Reports
MORE >
Sign Up for IR Weekly Newsletter Details
Sign Up for this Company Alerts Details
Contact Quam IR
Tel: 2217-2912
Email : quamir@quamgroup.com
Contact XINGLIN MEDICAL

To request additional information on this company, please complete the form below and we will contact the company on your behalf.

Name:*
Company:
Position:
Phone:
E-mail:*
Existing Shareholder: Yes No
Message:*  

* Required Fields
News / Press Releases
05 Jul 2010
Xing Lin Medical (08130) proposes capital reorganisation
05 Jul 2010
Xing Lin Medical FY09/10 turnover surged 11x
30 Jun 2010
Xing Lin (08130) FY10 NL widens to $74M; no fin div
03 May 2010
Xing Lin Medical Proposes 1-for-4 Open Offer
03 May 2010
Xing Lin Medical to raise at least $183M in open offer
MORE >
Event Calendar
Week Of25 Jul - 24 002010
MORE MONTH>
Quam IR:
Sitemap  |  About Us  |  Contact Us  |  Disclaimers     English | 繁體 | 简体  
Quam Group:
Quam Limited  |  Quam Capital  |  Quam Securities
Quam Wealth  |  Quamnet
Partners:
Japan  |  Thailand  |  Dubai
Information of Quam IR (Investor Relations):
[Hong Kong Listed Company Information] [Financial News] [Announcement Alerts] [Free Delayed Stock Quote] [Chart]
[Hong Kong stock information]

QuamIR (Investor Relations) Services:
[Listed Companies Information] [Listed Companies Financial Information] [Listed Companies Announcements]
[Listed Companies Circulars] [Listed Companies News] [Press Releases] [Listed Companies Event Calendar]
[Listed Companies Presentations] [Proxy Forms]

Quam IR (Investor Relations):
[Securities Firms] [Fund Houses] [Venture Capitals] [Financial Public Relations Agencies] [Financial Printers]
Investor Relations Dictionary:
[Listed Companies Result Announcement] [Financial Report] [Interim Report] [Annual General Meeting]
[Extraordinary General Meeting] [Board Meeting] [Annual Report] [Contact Listed Companies Investor Relations]
[Company Information Sheet] [Next Day Disclosure Return] [News Release] [IPO] [Prospectus] [Stock Quote] [Trading Volume]